OneMedNet 10% Owner Purchased Shares Worth Over $750K

Kosasa Thomas, a 10% owner and director of OneMedNet, bought 129,758 shares at $5.78 each, totaling $750,001 on October 7, 2026. Post-purchase, they own 1,983,573 shares. The price was based on the 10-day VWAP prior to the transaction, according to an SEC filing.

Original reporting
Published Oct 14, 2026, 12:40 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2026, 12:45 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
OneMedNet 10% Owner Purchased Shares Worth Over $750K — source image
Decision brief

The 30-second read

$ONMDNeutralLow
01

Why it matters

The insider purchase modestly raises the director's ownership to ~2.5% of the company, suggesting personal confidence but unlikely to move the stock significantly.

02

Market read

Primary disclosure of an insider purchase; modest size limits trading relevance.

03

What to watch

Potential upcoming clinical data or financing events not disclosed in the filing.

Relevance 4/10Novelty 4/10Timing: post‑market reaction

Background

OneMedNet Inc. (NASDAQ: ONMD) filed a Form 4 on October 7, 2026, reporting a director's purchase of 129,758 shares.

Company-level read

Ticker impact

$ONMDNeutralMedium confidence
Context

Form 4 filing shows a 10% owner/director bought 129,758 shares at $5.78, increasing his stake to 1,983,573 shares.

Expected impact

slight upward pressure as the market prices in insider confidence

Evidence & confidence

Purchase size (~$750k) is modest for a micro‑cap; typical insider buys can nudge price modestly but unlikely to drive a large move.

Market effects

None; the filing pertains only to OneMedNet and does not affect its sector.

Limited to investors tracking micro‑cap biotech stocks.

Low; no broader market impact.

Counterpoint

The purchase could be a routine portfolio rebalancing rather than a strong bullish signal.

Key entities

  • Kosasa Thomas

    Purchased 129,758 shares at $5.78 per share.

  • OneMedNet Inc.

    Micro‑cap biotech listed on NASDAQ.

Related articles

$ONMDLow

OneMedNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook

OneMedNet Corp (ONMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE OneMedNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook MINNEAPOLIS, NOVEMBER 6, 2026 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provi

$HIMSMed

Why is Hims & Hers Health stock rallying today?

Hims & Hers Health (HIMS) stock rose 5.7% after partnering with Eli Lilly to sell weight-loss drugs Zepbound and Foundayo via its telehealth platform. The deal mirrors a prior agreement with Novo Nordisk, reflecting a shift to FDA-approved obesity medications. Q3 earnings are expected to show $892.88M in revenue. The broader market also gained, with the S&P 500 and Nasdaq rising 0.59% and 1.17%, respectively.